These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


97 related items for PubMed ID: 1870263

  • 1. [Domain structure of human von Willebrand factor, and its modulators involved in the platelet adhesion process in vitro].
    Fujimura Y, Fukui H, Usami Y, Titani K.
    Rinsho Ketsueki; 1991 May; 32(5):475-80. PubMed ID: 1870263
    [Abstract] [Full Text] [Related]

  • 2. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation.
    Andrews RK, Kroll MH, Ward CM, Rose JW, Scarborough RM, Smith AI, López JA, Berndt MC.
    Biochemistry; 1996 Sep 24; 35(38):12629-39. PubMed ID: 8823201
    [Abstract] [Full Text] [Related]

  • 3. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
    Hoylaerts MF.
    Verh K Acad Geneeskd Belg; 1997 Sep 24; 59(3):161-83. PubMed ID: 9490916
    [Abstract] [Full Text] [Related]

  • 4. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
    Rivera J, Escolar G, Casamiquela R, Bravo MI, Jorquera JI, Castillo R, Ordinas A, Vicente V.
    Haematologica; 1999 Jan 24; 84(1):5-11. PubMed ID: 10091386
    [Abstract] [Full Text] [Related]

  • 5. Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca.
    Fujimura Y, Titani K, Usami Y, Suzuki M, Oyama R, Matsui T, Fukui H, Sugimoto M, Ruggeri ZM.
    Biochemistry; 1991 Feb 19; 30(7):1957-64. PubMed ID: 1993206
    [Abstract] [Full Text] [Related]

  • 6. Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib.
    Fujimura Y, Ikeda Y, Miura S, Yoshida E, Shima H, Nishida S, Suzuki M, Titani K, Taniuchi Y, Kawasaki T.
    Thromb Haemost; 1995 Aug 19; 74(2):743-50. PubMed ID: 8585016
    [Abstract] [Full Text] [Related]

  • 7. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
    Tornai I, Arnout J, Deckmyn H, Peerlinck K, Vermylen J.
    J Clin Invest; 1993 Jan 19; 91(1):273-82. PubMed ID: 8423224
    [Abstract] [Full Text] [Related]

  • 8. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin.
    Berndt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews RK.
    Biochemistry; 1992 Nov 17; 31(45):11144-51. PubMed ID: 1359905
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the structure and function of the von Willebrand factor A1 domain using targeted deletions and alanine-scanning mutagenesis.
    Kroner PA, Frey AB.
    Biochemistry; 1996 Oct 15; 35(41):13460-8. PubMed ID: 8873615
    [Abstract] [Full Text] [Related]

  • 10. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
    Andrews RK, Booth WJ, Gorman JJ, Castaldi PA, Berndt MC.
    Biochemistry; 1989 Oct 17; 28(21):8317-26. PubMed ID: 2557900
    [Abstract] [Full Text] [Related]

  • 11. The interaction of botrocetin with normal or variant von Willebrand factor (types IIA and IIB) and its inhibition by monoclonal antibodies that block receptor binding.
    Fujimura Y, Miyata S, Nishida S, Miura S, Kaneda M, Yoshioka A, Fukui H, Katayama M, Tuddenham EG, Usami Y.
    Thromb Haemost; 1992 Oct 05; 68(4):464-9. PubMed ID: 1280375
    [Abstract] [Full Text] [Related]

  • 12. Structure and function of snake venom toxins interacting with human von Willebrand factor.
    Matsui T, Hamako J.
    Toxicon; 2005 Jun 15; 45(8):1075-87. PubMed ID: 15922776
    [Abstract] [Full Text] [Related]

  • 13. von Willebrand factor without the A2 domain is resistant to proteolysis.
    Lankhof H, Damas C, Schiphorst ME, Ijsseldijk MJ, Bracke M, Furlan M, Tsai HM, de Groot PG, Sixma JJ, Vink T.
    Thromb Haemost; 1997 May 15; 77(5):1008-13. PubMed ID: 9184419
    [Abstract] [Full Text] [Related]

  • 14. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
    Danton MC, Zaleski A, Nichols WL, Olson JD.
    J Lab Clin Med; 1994 Aug 15; 124(2):274-82. PubMed ID: 8051492
    [Abstract] [Full Text] [Related]

  • 15. Molecular genetics of von Willebrand disease.
    Mazurier C, Ribba AS, Gaucher C, Meyer D.
    Ann Genet; 1998 Aug 15; 41(1):34-43. PubMed ID: 9599650
    [Abstract] [Full Text] [Related]

  • 16. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.
    Matsushita T, Sadler JE.
    J Biol Chem; 1995 Jun 02; 270(22):13406-14. PubMed ID: 7539426
    [Abstract] [Full Text] [Related]

  • 17. Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium.
    Weiss HJ, Hoffmann T, Yoshioka A, Ruggeri ZM.
    J Lab Clin Med; 1993 Sep 02; 122(3):324-32. PubMed ID: 8409708
    [Abstract] [Full Text] [Related]

  • 18. Purification and characterization of bitiscetin, a novel von Willebrand factor modulator protein from Bitis arietans snake venom.
    Hamako J, Matsui T, Suzuki M, Ito M, Makita K, Fujimura Y, Ozeki Y, Titani K.
    Biochem Biophys Res Commun; 1996 Sep 04; 226(1):273-9. PubMed ID: 8806626
    [Abstract] [Full Text] [Related]

  • 19. Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor.
    Inbal A, Kornbrot N, Harrison P, Randi AM, Sadler JE.
    Thromb Haemost; 1993 Dec 20; 70(6):1058-62. PubMed ID: 8165601
    [Abstract] [Full Text] [Related]

  • 20. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y, Zhang W, Yan R, Liao Y, Zhao L, Ruan C, Du X, Dai K.
    Circ Res; 2009 Dec 04; 105(12):1177-85. PubMed ID: 19875727
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.